Skip to content

Author

C. Hedin

We have 3 of 27 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Risk of Inflammatory Bowel Disease After Anti-CD20 Treatment in Multiple Sclerosis

This cohort study investigates if anti-CD20 treatment is associated with an increase in the risk of inflammatory bowel disease in individuals with multiple sclerosis (MS).

Sandra Kallin, A. Svenningsson, O. Olén et al. · 0 citations
Open access Aug 2026

The Utility of Faecal Biomarkers in the Discrimination Between Acute Gastroenteritis and Inflammatory Bowel Disease

Faecal biomarkers reflecting neutrophil, eosinophil, and epithelial activity may provide complementary information in the differentiation of patients with suspected acute GE and new-onset IBD, suggesting that faecal HNL may have the ability to distinguish between these conditions.

M. Lundström, Christer G. B. Peterson, David Amcoff et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.